DK0780369T3 - 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer - Google Patents

1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer

Info

Publication number
DK0780369T3
DK0780369T3 DK96119283T DK96119283T DK0780369T3 DK 0780369 T3 DK0780369 T3 DK 0780369T3 DK 96119283 T DK96119283 T DK 96119283T DK 96119283 T DK96119283 T DK 96119283T DK 0780369 T3 DK0780369 T3 DK 0780369T3
Authority
DK
Denmark
Prior art keywords
cyclohexan
dimethylaminomethyl
phenyl
compounds
active substances
Prior art date
Application number
DK96119283T
Other languages
Danish (da)
English (en)
Inventor
Ivars Dr Graudums
Werner Prof Dr Winter
Ernst Dr Frankus
Wolfgang Werner A Strassburger
Elmar Josef Dr Friderichs
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK0780369T3 publication Critical patent/DK0780369T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/32Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96119283T 1995-12-20 1996-12-02 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer DK0780369T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19547766A DE19547766A1 (de) 1995-12-20 1995-12-20 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe

Publications (1)

Publication Number Publication Date
DK0780369T3 true DK0780369T3 (da) 2000-06-13

Family

ID=7780779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96119283T DK0780369T3 (da) 1995-12-20 1996-12-02 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer

Country Status (23)

Country Link
US (1) US5801201A (pt)
EP (1) EP0780369B1 (pt)
JP (1) JP3987598B2 (pt)
KR (1) KR100439283B1 (pt)
CN (1) CN1071309C (pt)
AR (1) AR004357A1 (pt)
AT (1) ATE188961T1 (pt)
AU (1) AU705970B2 (pt)
CA (1) CA2193337C (pt)
CO (1) CO4480100A1 (pt)
DE (2) DE19547766A1 (pt)
DK (1) DK0780369T3 (pt)
ES (1) ES2144192T3 (pt)
GR (1) GR3032486T3 (pt)
HK (1) HK1001860A1 (pt)
HU (1) HU223340B1 (pt)
IL (1) IL119864A (pt)
PE (1) PE25498A1 (pt)
PL (1) PL185813B1 (pt)
PT (1) PT780369E (pt)
RU (1) RU2167148C2 (pt)
SI (1) SI0780369T1 (pt)
ZA (1) ZA9610650B (pt)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19830105C1 (de) 1998-07-06 2000-02-17 Gruenenthal Gmbh Acridinderivate
DE10000312A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
DE10000311A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Aminomethyl-Phonyl-Cyclohexanonderivate
DE10004926A1 (de) 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
DE10049481A1 (de) 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
DE60211689T2 (de) 2001-03-16 2007-01-11 DMI Biosciences, Inc., Englewood Verwendung von Tramadol zur Verzögerung der Ejakulation
US6649783B2 (en) * 2001-10-03 2003-11-18 Euro-Celtique, S.A. Synthesis of (+/-)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols
DE10161818A1 (de) 2001-12-14 2003-06-26 Gruenenthal Gmbh Substituierte 1,5-Diaminopentan-3-ol-Verbindungen
DE10164581A1 (de) 2001-12-14 2003-06-26 Gruenenthal Gmbh Substituierte Aminoalkohole
DE10206405A1 (de) * 2002-02-14 2003-08-28 Gruenenthal Gmbh Synthese von substituierten Carbamidestern
DE10206403A1 (de) * 2002-02-14 2003-08-28 Gruenenthal Gmbh Synthese von Beta-Aminoketonen
DE10213051B4 (de) * 2002-03-23 2013-03-07 Grünenthal GmbH Substituierte 4-Aminocyclohexanole
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005033732B4 (de) 2005-05-27 2014-02-13 Grünenthal GmbH Trennung stereoisomerer N,N-Dialkylamino-2-alkyl-3-hydroxy-3-phenyl-alkane
DE202005014347U1 (de) 2005-09-09 2007-01-18 Grünenthal GmbH Applikationssystem für ein wirkstoffhaltiges Pflaster und Wirkstoffabgaberegulierungsmittel
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
MX2010003394A (es) * 2007-09-28 2010-04-09 Daiichi Sankyo Co Ltd Derivado de gamma-aminoacido biciclico.
BRPI0906467C1 (pt) 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
PL2262757T3 (pl) * 2008-02-29 2011-12-30 Gruenenthal Gmbh Sposób wytwarzania 6-dimetyloaminometylo-fenylo-cykloheksano-1,3-dioli
EP2262759A1 (de) 2008-02-29 2010-12-22 Grünenthal GmbH Verfahren zur herstellung von (1rs,3rs,6rs)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexan-1,3-diol
LT2273983T (lt) 2008-05-09 2016-10-25 Grünenthal GmbH Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
KR101747156B1 (ko) 2009-07-22 2017-06-27 그뤼넨탈 게엠베하 산화-안정화된 탬퍼-내성 용량형
TW201105316A (en) 2009-07-22 2011-02-16 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
CN102821757B (zh) 2010-02-03 2016-01-20 格吕伦塔尔有限公司 通过挤出机制备粉末状药物组合物
MX2013002377A (es) 2010-09-02 2013-04-29 Gruenenthal Gmbh Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
RU2607499C2 (ru) 2010-09-02 2017-01-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
EA201400173A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
JP6282261B2 (ja) 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
CA2917136C (en) 2013-07-12 2022-05-31 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
AU2015261060A1 (en) 2014-05-12 2016-11-03 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising Tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
MX2017013637A (es) 2015-04-24 2018-03-08 Gruenenthal Gmbh Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
US10781163B2 (en) 2017-09-18 2020-09-22 R L Finechem Private Limited Process for preparation of O-Desmethyltramadol and salts thereof
US20230027752A1 (en) * 2019-11-06 2023-01-26 Fudan University Opioid receptor agonist, preparation method therefor and pharmaceutical use thereof
CN112759538B (zh) * 2019-11-06 2022-01-18 复旦大学 3-(二甲氨基甲基)环己-4-醇衍生物及其制备方法和药物用途
CN112759546B (zh) * 2019-11-06 2022-08-26 复旦大学 3-(二甲氨基甲基)哌啶-4-醇衍生物及其制备方法和药物用途
CN112759544B (zh) * 2019-11-06 2022-08-26 复旦大学 3-(二甲氨基甲基)哌啶-4-醇衍生物制备方法和药物用途
CN112759545B (zh) * 2019-11-06 2022-12-13 复旦大学 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途
CN112759587B (zh) * 2019-11-06 2022-12-30 复旦大学 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE616646A (pt)
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
JPS51143650A (en) * 1975-06-06 1976-12-10 Takeda Chem Ind Ltd A process for preparing cyclohexanol derivatives

Also Published As

Publication number Publication date
RU2167148C2 (ru) 2001-05-20
HU9603495D0 (en) 1997-02-28
IL119864A (en) 2004-05-12
PT780369E (pt) 2000-06-30
PL185813B1 (pl) 2003-08-29
KR19980049739A (ko) 1998-09-15
ZA9610650B (en) 1997-06-27
GR3032486T3 (en) 2000-05-31
AU705970B2 (en) 1999-06-03
CA2193337C (en) 2005-09-27
ES2144192T3 (es) 2000-06-01
DE19547766A1 (de) 1997-06-26
HUP9603495A3 (en) 1998-04-28
HK1001860A1 (en) 1998-07-17
CN1071309C (zh) 2001-09-19
EP0780369B1 (de) 2000-01-19
HUP9603495A2 (en) 1997-12-29
JP3987598B2 (ja) 2007-10-10
KR100439283B1 (ko) 2004-09-16
EP0780369A1 (de) 1997-06-25
CO4480100A1 (es) 1997-07-09
CN1157815A (zh) 1997-08-27
IL119864A0 (en) 1997-03-18
PE25498A1 (es) 1998-05-23
CA2193337A1 (en) 1997-06-21
JPH09221460A (ja) 1997-08-26
AR004357A1 (es) 1998-11-04
PL317595A1 (en) 1997-06-23
ATE188961T1 (de) 2000-02-15
SI0780369T1 (en) 2000-04-30
HU223340B1 (hu) 2004-06-28
DE59604226D1 (de) 2000-02-24
AU7547196A (en) 1997-06-26
MX9606264A (es) 1997-10-31
US5801201A (en) 1998-09-01

Similar Documents

Publication Publication Date Title
DK0753506T3 (da) 6-Dimethylaminomethyl-1-phenyl-cyclohexanforbindelser som farmaceutisk aktive stoffer
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
EE9800116A (et) Farmatseutiliselt aktiivsed kinasoliini ühendid
DK0983995T3 (da) Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser som farmaceutiske, aktive stoffer
BR9610396A (pt) Formulação farmacêutica
BR9610214A (pt) Compostos farmacéuticos
AU2080199A (en) New pharmaceutically active compounds
NO980923D0 (no) Optisk aktivt fenylpyrimidin-derivat som analgetisk middel
NO20012965D0 (no) Sulfonyloksazolaminer som terapeutisk aktive forbindelser
DE59609922D1 (de) Wirkstoffkombinationen
FI973230A (fi) Uusi farmaseuttinen formulaatio
TR199601018A1 (tr) Farmasötik bilesikler.
DK0770603T3 (da) Alkynylphenylaminosulfonylurinstoffer som herbicider
SE9700660D0 (sv) Pharmaceutically active compounds
SE9704874D0 (sv) New pharmaceutically active compounds
FI2111U1 (fi) Bygel som foerbaettrar kontrollen oever kryckkaeppar
FI931345A0 (fi) Tjuvalarm, som aktiveras av foeremaolets, som skall skyddas, roerelse
FI953583A0 (fi) Delningskniv som flyttar stycken som skall saogas laengre ut fraon skaeret
GB9509942D0 (en) Pharmaceutically active compounds
GB9505076D0 (en) Pharmaceutically active compounds
GB9502429D0 (en) Pharmaceutically active compounds
GB9510406D0 (en) Pharmaceutically active compounds
GB9500099D0 (en) Pharmaceutically active compounds
GB9507641D0 (en) Pharmaceutically active compounds
GB9500427D0 (en) Pharmaceutically active compounds